Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Opioid Analgesic Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Opioid Analgesic Trends and Forecast

The future of the global opioid analgesic market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets. The global opioid analgesic market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing need for pain treatment following surgery, improvements in medication formulations to reduce the negative effects of analgesics, as well as, increasing rates of orthopedic diseases and persistent pain in the elderly.
• Lucintel forecasts, within the route of administration category, that oral is expected to witness the highest growth over the forecast period because it is the most practical and economical method of administering opioid analgesics.
• In terms of regions, North America is expected to witness highest growth over the forecast period.

Gain valuable insight for your business decisions with our comprehensive 150+ page report
Opioid Analgesic Trends and Forecast

Opioid Analgesic by Segment

Emerging Trends in the Opioid Analgesic Market

The future of pain management is being shaped by emerging trends in the opioid analgesic market, which are also addressing concerns about opioid use and abuse.

• Abuse-Deterrent Formulations: Concerns about nonmedical utilization or addiction have caused the invention of these formulations that build on technologies with built-in capacities to limit accessibility for misuse. Consequently, drugs can hardly be modified for purposes other than medication to improve safety measures.
• Non-Opioid Alternatives: There is an increasing focus on non-opioid analgesic research and development, especially as risk mitigation toward acetaminophen and anti-inflammatory drugs regarding opiate use.
• Enhanced Prescription Monitoring: More advanced prescription monitoring programs have been introduced to trace opioid prescriptions more effectively. The purpose of such programs is to minimize over-prescribing and identify potential misuse.
• Patient-Centric Approaches: A shift towards patient-centric pain management includes personalized treatment plans and better patient education, which helps patients comply with their treatment and achieve better outcomes.

These developments have made the opioid analgesic market safer while also promoting alternative approaches and enhancing general methods for managing pain.
Emerging Trends in the Opioid Analgesic Market

Recent Developments in the Opioid Analgesic Market

The opioid analgesic market has witnessed key changes and modifications in treatment approaches and regulatory environments.

• New technology against abuse: The invention of new technologies to counteract the potential for opioid abuse in their formulation has made them harder to crush, dissolve, or inject, thereby improving safety.
• Tougher regulations: Regulators are moving toward more stringent requirements for opioid prescribing and dispensing. Such measures entail strengthened tracking systems as well as restrictions on the amount of opioids that can be prescribed.
• Broadening the scope of non-opioid alternatives: The market is expanding with the development of effective non-opioid pain management options. These substitutes are increasingly being seen as safer options for treating pain while mitigating addiction risks.
• Better Prescription Monitoring Programs: Prescription monitoring programs have been improved to keep track of opioid usage and prevent abuse. They offer better information about prescription habits and patient conduct than previous methods.

These developments shape the modern marketplace by advancing security features, enhancing guideline structures, and extending channels for therapy within the realm of opioid analgesics.

Strategic Growth Opportunities for Opioid Analgesic Market

Various applications in the opioid analgesic market provide strategic growth opportunities driven by innovation and evolving healthcare needs.

• Chronic Pain Management: Opportunities exist to advance opioid formulation for chronic pain management, focusing on long-term effectiveness and safety. To this end, adherence and patient outcomes are expected to improve.
• Abuse-Deterrent Technologies: Investments in abuse-deterrent technologies create room for growth. These advancements promote medication safety and address concerns about addiction and misuse of opioids.
• Non-Opioid Alternatives: There is potential for expansion in creating non-opioid alternatives for managing pain. This transition provides safer options and reduces reliance on opioids.
• Prescription Monitoring Solutions: Growth prospects emerge through developing next-generation prescription monitoring solutions. These systems enhance traceability, prevent misuse, and ensure regulatory compliance.

These development opportunities are remodeling the opioid analgesics market by diversifying treatment options and improving safety while dealing with challenges surrounding opiate use.

Opioid Analgesic Market Driver and Challenges

The opioid analgesic market is influenced by a range of drivers and challenges shaped by technological, economic, and regulatory factors.

The factors responsible for driving the opioid analgesic market include:
• Technological Innovations: Advances in drug formulation and delivery technologies are driving the development of safer, more effective opioids. Innovations such as abuse-deterrent formulations improve safety for patients.
• Growing Demand for Pain Management: In response to the increasing prevalence of chronic pain conditions, there has been an increased demand for effective pain management solutions. Opioids continue to be essential alternatives for managing severe pain.
• Regulatory Support for Research: Support from government and regulatory agencies for research toward opiate alternatives and abuse-deterrent technology drives growth in the market.
• Patient Safety Initiatives: Efforts focused on improving patient safety while reducing opioid misuse have led to the creation of new medications and monitoring systems.

Challenges in the opioid analgesic market include:
• Regulatory Restrictions: Regulatory restrictions can be stringent regarding opioid prescribing, inhibiting market growth, especially concerning drug availability. Market operations become more complicated due to compliance with these guidelines.
• Addiction and Misuse Concerns: Opioids have significant addiction risks and are prone to misuse, posing serious challenges. Alleviating these issues demands continuous innovation and monitoring.

These drivers, along with challenges, collectively influence growth opportunities, regulatory standards and practices, and overall market dynamics within which the opioid analgesic industry operates.

List of Opioid Analgesic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies opioid analgesic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the opioid analgesic companies profiled in this report include-
• Pfizer
• Abbott Laboratories
• Janssen Pharmaceuticals
• Novartis
• Bayer
• GlaxoSmithKline
• F. Hoffmann-La Roche
• Boehringer Ingelheim
• Bausch
• Sanofi

Opioid Analgesic by Segment

The study includes a forecast for the global opioid analgesic by drug class, indication, route of administration, end use, and region.

Opioid Analgesic Market by Drug Class [Analysis by Value from 2018 to 2030]:


• Morphine
• Codeine
• Fentanyl
• Meperidine
• Methadone
• Tramadol
• Oxycodone
• Dextromethorphan
• Buprenorphine
• Others

Opioid Analgesic Market by Indication [Analysis by Value from 2018 to 2030]:


• Surgical Pain
• Cancer Pain
• Neuropathic Pain
• Others

Opioid Analgesic Market by Route of Administration [Analysis by Value from 2018 to 2030]:


• Oral
• Parenteral
• Transdermal
• Others

Opioid Analgesic Market by End Use [Analysis by Value from 2018 to 2030]:


• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

Opioid Analgesic Market by Region [Shipment Analysis by Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Opioid Analgesic Market

Current trends in the opioid analgesic market indicate progressions driven by regulatory pressures, innovations, and changing treatment modalities.

• United States: The United States is shifting towards abuse-deterrent formulations and non-opioid alternatives as it grapples with tight regulations on drug use and a crisis of opioid dependence. New policies have started to enforce more rigorous prescribing practices while extending the reach of addiction treatment services.
• China: In China, there is a growing emphasis on improving pain management approaches and strict regulation of opioid use. The market is now seeing greater exploration into safer opioid substitutes as well as improved monitoring systems aimed at preventing misuse.
• Germany: Germany has made strides toward developing opioids with a lower potential for abuse and has implemented stricter guidelines for prescribing. Recent changes also include an increased emphasis on patient education and support to manage chronic pain effectively.
• India: In India, effective pain management solutions are increasingly sought after due to heightened awareness about opioid dependency cases. Improving access to regulated opiate therapies is being done while maintaining a balance between addressing pain control issues and addiction demands.
• Japan: Japan focuses on incorporating advanced technologies for managing pain and enhancing regulatory frameworks concerning opioids. Recent developments here include the introduction of new dosage forms; therefore, greater attention is paid to patient healthcare safety, and there is better awareness regarding addiction problems.
Lucintel Analytics Dashboard

Features of the Global Opioid Analgesic Market

Market Size Estimates: Opioid analgesic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Opioid analgesic market size by drug class, indication, route of administration, end use, and region in terms of value ($B).
Regional Analysis: Opioid analgesic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug class, indication, route of administration, end use, and regions for the opioid analgesic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the opioid analgesic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
Lucintel Consulting Services

FAQ

Q• What is the growth forecast for opioid analgesic market?
Answer: The global opioid analgesic market is expected to grow with a CAGR of 5.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the opioid analgesic market?
Answer: The major drivers for this market are growing need for pain treatment following surgery, improvements in medication formulations to reduce the negative effects of analgesics, as well as, increasing rates of orthopedic diseases and persistent pain in the elderly.
Q3. What are the major segments for opioid analgesic market?
Answer: The future of the global opioid analgesic market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets.
Q4. Who are the key opioid analgesic market companies?
Answer: Some of the key opioid analgesic companies are as follows:
• Pfizer
• Abbott Laboratories
• Janssen Pharmaceuticals
• Novartis
• Bayer
• GlaxoSmithKline
• F. Hoffmann-La Roche
• Boehringer Ingelheim
• Bausch
• Sanofi
Q5. Which opioid analgesic market segment will be the largest in future?
Answer: Lucintel forecasts that oral is expected to witness the highest growth over the forecast period because it is the most practical and economical method of administering opioid analgesics.
Q6. In opioid analgesic market, which region is expected to be the largest in next 5 years?
Answer: • In terms of regions, North America is expected to witness highest growth over the forecast period.
Q.7 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.• What are some of the most promising, high-growth opportunities for the opioid analgesic market by drug class (morphine, codeine, fentanyl, meperidine, methadone, tramadol, oxycodone, dextromethorphan, buprenorphine, and others), indication (surgical pain, cancer pain, neuropathic pain, and others), route of administration (oral, parenteral, transdermal, and others), end use (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.1• What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Opioid Analgesic Market, Opioid Analgesic Market Size, Opioid Analgesic Market Growth, Opioid Analgesic Market Analysis, Opioid Analgesic Market Report, Opioid Analgesic Market Share, Opioid Analgesic Market Trends, Opioid Analgesic Market Forecast, Opioid Analgesic Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.

                                                            Table of Contents

            1. Executive Summary

            2. Global Opioid Analgesic Market : Market Dynamics
                        2.1: Introduction, Background, and Classifications
                        2.2: Supply Chain
                        2.3: Industry Drivers and Challenges 

            3. Market Trends and Forecast Analysis from 2018 to 2030
                        3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
                        3.2. Global Opioid Analgesic Market Trends (2018-2023) and Forecast (2024-2030)
                        3.3: Global Opioid Analgesic Market by Drug Class
                                    3.3.1: Morphine
                                    3.3.2: Codeine
                                    3.3.3: Fentanyl
                                    3.3.4: Meperidine
                                    3.3.5: Methadone
                                    3.3.6: Tramadol
                                    3.3.7: Oxycodone
                                    3.3.8: Dextromethorphan
                                    3.3.9: Buprenorphine
                        3.4: Global Opioid Analgesic Market by Indication
                                    3.4.1: Surgical Pain
                                    3.4.2: Cancer Pain
                                    3.4.3: Neuropathic Pain
                                    3.4.4: Others
                        3.5: Global Opioid Analgesic Market by Route of Administration
                                    3.5.1: Oral
                                    3.5.2: Parenteral
                                    3.5.3: Transdermal
                                    3.5.4: Others
                                    3.6: Global Opioid Analgesic Market by End Use
                                    3.6.1: Hospital Pharmacies
                                    3.6.2: Retail Pharmacies
                                    3.6.3: Drug Stores
                                    3.6.4: Online Pharmacies

            4. Market Trends and Forecast Analysis by Region from 2018 to 2030
                        4.1: Global Opioid Analgesic Market by Region
                        4.2: North American Opioid Analgesic Market
                                    4.2.1: North American Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
                                    4.2.2: North American Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
                        4.3: European Opioid Analgesic Market
                                    4.3.1: European Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
                                    4.3.2: European Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
                        4.4: APAC Opioid Analgesic Market
                                    4.4.1: APAC Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
                                    4.4.2: APAC Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies
                        4.5: ROW Opioid Analgesic Market
                                    4.5.1: ROW Market by Route of Administration: Oral, Parenteral, Transdermal, and Others
                                    4.5.2: ROW Market by End Use: Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies

            5. Competitor Analysis
                        5.1: Product Portfolio Analysis
                        5.2: Operational Integration
                        5.3: Porter’s Five Forces Analysis

            6. Growth Opportunities and Strategic Analysis
                        6.1: Growth Opportunity Analysis
                                    6.1.1: Growth Opportunities for the Global Opioid Analgesic Market by Drug Class
                                    6.1.2: Growth Opportunities for the Global Opioid Analgesic Market by Indication
                                    6.1.3: Growth Opportunities for the Global Opioid Analgesic Market by Route of Administration
                                    6.1.4: Growth Opportunities for the Global Opioid Analgesic Market by End Use
                                    6.1.5: Growth Opportunities for the Global Opioid Analgesic Market by Region
                        6.2: Emerging Trends in the Global Opioid Analgesic Market
                        6.3: Strategic Analysis
                                    6.3.1: New Product Development
                                    6.3.2: Capacity Expansion of the Global Opioid Analgesic Market
                                    6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Opioid Analgesic Market
                                    6.3.4: Certification and Licensing

            7. Company Profiles of Leading Players
                        7.1: Pfizer
                        7.2: Abbott Laboratories
                        7.3: Janssen Pharmaceuticals
                        7.4: Novartis
                        7.5: Bayer
                        7.6: GlaxoSmithKline
                        7.7: F. Hoffmann-La Roche
                        7.8: Boehringer Ingelheim
                        7.9: Bausch
                        7.10: Sanofi
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Opioid Analgesic Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Opioid Analgesic Market Report.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )

Follow us on